Interferon-beta 1a and SARS coronavirus replication.

Category Primary study
JournalEmerging infectious diseases
Year 2004
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon-beta 1a potently inhibits SARS coronavirus replication in vitro.
Epistemonikos ID: 466635f27581df4b956592fe5335829fcb589515
First added on: Mar 19, 2020